Germany Severe Asthma Index

Germany scores slightly above average in terms of Access and Care Coverage, with high access to treatment, including biologics and digital therapeutics. Access to diagnostics is adequate, but FeNO is not reimbursed except for therapy initiation with biologics and also not widely utilised. In terms of Policy Context, Germany demonstrates a relatively high level of implementation of severe asthma guidelines and has guidelines in alignment with international best practices. Germany has the lowest score on Health System Characteristics due to a high average number of days spent in the hospital along with a relatively low number of respiratory specialists.